Q2 EPS Estimate for ACADIA Pharmaceuticals Cut by Analyst
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Zacks Research lowered their Q2 2025 EPS estimates for shares of ACADIA Pharmaceuticals in a note issued to investors on Wednesday, May 28th. Zacks Research analyst A. Chakraborty now expects that the biopharmaceutical company will post earnings of $0.14 per share for the quarter, down from their […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Zacks Research lowered their Q2 2025 EPS estimates for shares of ACADIA Pharmaceuticals in a note issued to investors on Wednesday, May 28th. Zacks Research analyst A. Chakraborty now expects that the biopharmaceutical company will post earnings of $0.14 per share for the quarter, down from their […]
